• roche logo

 

The devil is in the details.

Get the facts. Know her risk.


The cobas® HPV Test: 3 hrHPV RESULTS in one test for confident risk stratification1

cobas® HPV Test 3 in 1

The detail to make decisions based upon your patient’s real risk

The cobas®  HPV Test is the only clinically validated, FDA-approved assay that simultaneously provides pooled results on high-risk genotypes and individual results on the highest-risk genotypes, HPV 16 and HPV 18.  

The cobas® HPV Test has the potential to set a new standard of testing:

  • Significantly enhances risk stratification
  • Lets you focus on the few women who need aggressive treatment
  • Lets you reassure the vast majority of women that they are at very low risk


Confidence with the cobas® HPV Test

Precise results you can trust

The cobas® HPV Test offers:

  • No cross-reactivity with low-risk HPV types
  • Results are positive, negative, or invalid with no gray zone
  • Reproducible results with real-time PCR
     

Reduced false negatives1

  • ß-globin internal control for sample adequacy
     

Reduced false positives1

  • External control
  • No cross-reactivity with low-risk HPV genotypes
     

For additional technical specifications on the cobas®  HPV Test, visit Roche US Diagnostics.


  • Acronyms:

References:

1. cobas® 4800 HPV Test US package insert. April 2016.